Familial Nasopharyngeal Carcinoma 6

Pathogenesis and Etiology of Nasopharyngeal Carcinoma 23Murray PG, Young LS (2000) Themed issue: the biology andpathology of the Epstein–Barr virus. Mol Pathol53(5):219–221Murray RJ, Kurilla MG, Brooks JM, et al (1992) Identification oftarget antigens for the human cytotoxic T cell response toEpstein–Barr virus (EBV): implications for the immune controlof EBV-positive malignancies. J Exp Med 176(1):157–168Nasrin N, Taiba K, Hannan N, et al (1994) A molecular study ofEBV DNA and p53 mutations in nasopharyngeal carcinomaof Saudi Arab patients. Cancer Lett 82(2):189–198Nazar-Stewart V, Vaughan TL, Burt RD, et al (1999) GlutathioneS-transferase M1 and susceptibility to nasopharyngeal carcinoma.Cancer Epidemiol Biomarkers Prev 8(6):547–551Nemerow GR, Mold C, Schwend VK, et al (1987) Identificationof gp350 as the viral glycoprotein mediating attachment ofEpstein–Barr virus (EBV) to the EBV//C3d receptor of Bcells: sequence homology of gp350 and C3 complementfragment C3d. J Virol 61(5):1416–1420Niedobitek G (2000) Epstein–Barr virus infection in the pathogenesisof nasopharyngeal carcinoma. Mol Pathol 53(5):248–254Niedobitek G, Agathanggelou A, Barber P, et al (1993) P53overexpression and Epstein–Barr virus infection in undifferentiatedand squamous cell nasopharyngeal carcinomas.J Pathol 170(4):457–461Niedobitek G, Agathanggelou A, Nicholls JM (1996) Epstein–Barr virus infection and the pathogenesis of nasopharyngealcarcinoma: viral gene expression, tumour cellphenotype, and the role of the lymphoid stroma. SeminCancer Biol 7(4):165–174Niedobitek G, Agathanggelou A, Steven N, Young LS (2000)Epstein–Barr virus (EBV) in infectious mononucleosis:detection of the virus in tonsillar B lymphocytes but not indesquamated oropharyngeal epithelial cells. Mol Pathol53(1):37–42Niedobitek G, Hansmann ML, Herbst H, et al (1991) Epstein–Barr virus and carcinomas: undifferentiated carcinomasbut not squamous cell carcinomas of the nasopharynx areregularly associated with the virus. J Pathol 165(1):17–24Niedobitek G, Young LS (1994) Epstein–Barr virus persistenceand virus-associated tumours. Lancet 343(8893):333–335Niemhom S, Kitazawa S, Murao S, et al (2000) Co-expression ofp53 and bcl-2 may correlate to the presence of Epstein–Barr virus genome and the expression of proliferating cellnuclear antigen in nasopharyngeal carcinoma. Cancer Lett160(2):199–208Ning JP, Yu MC, Wang QS, et al (1990) Consumption of saltedfish and other risk factors for nasopharyngeal carcinoma(NPC) in Tianjin, a low-risk region for NPC in the People’sRepublic of China. J Natl Cancer Inst 82(4):291–296Old LJ, Boyse EA, Oettgen HF, et al (1966) Precipitating antibodyin human serum to an antigen present in cultured Burkitt’slymphoma cells. Proc Natl Acad Sci U S A 56(6):1699–1704Parkin DM, Muir CS (1992) Cancer incidence in five continents.Comparability and quality of data. IARC sci publ(120):45–173Pathmanathan R, Prasad U, Sadler R, et al (1995) Clonal proliferationsof cells infected with Epstein–Barr virus in preinvasivelesions related to nasopharyngeal carcinoma. N EnglJ Med 333(11):693–698Pfeffer S, Zavolan M, Grasser FA, et al (2004) Identification ofvirus-encoded microRNAs. Science 304(5671):734–736Pratt ZL, Kuzembayeva M, Sengupta S, et al (2009) The microR-NAs of Epstein–Barr virus are expressed at dramaticallydiffering levels among cell lines. VirologyRaab-Traub N (2002) Epstein–Barr virus in the pathogenesisof NPC. Semin Cancer Biol 12(6):431–441Raab-Traub N, Flynn K (1986) The structure of the termini ofthe Epstein–Barr virus as a marker of clonal cellular proliferation.Cell 47(6):883–889Rickinson A (2002) Epstein–Barr virus. Virus Res 82(1–2):109–113Rowe M (2001) Cell transformation induced by Epstein–Barrvirus – living dangerously. Semin Cancer Biology 11(6):403–405Roy NS, Nakano T, Keyoung HM, et al (2004) Telomeraseimmortalization of neuronally restricted progenitor cellsderived from the human fetal spinal cord. Nat Biotechnol22(3):297–305Sakai E, Tsuchida N (1992) Most human squamous cell carcinomasin the oral cavity contain mutated p53 tumorsuppressorgenes. Oncogene 7(5):927–933Sample J, Young L, Martin B, et al (1990) Epstein–Barr virustypes 1 and 2 differ in their EBNA-3A, EBNA-3B, andEBNA-3C genes. J Virol 64(9):4084–4092Sandvej K, Gratama JW, Munch M, et al (1997) Sequence analysisof the Epstein–Barr virus (EBV) latent membraneprotein-1 gene and promoter region: identification of fourvariants among wild-type EBV isolates. Blood 90(1):323–330Scholle F, Longnecker R, Raab-Traub N (1999) Epithelial celladhesion to extracellular matrix proteins induces tyrosinephosphorylation of the Epstein–Barr virus latent membraneprotein 2: a role for C-terminal Src kinase. J Virol73(6):4767–4775Sham JS, Wei WI, Zong YS, et al (1990) Detection of subclinicalnasopharyngeal carcinoma by fibreoptic endoscopy andmultiple biopsy. Lancet 335(8686):371–374Shanmugaratnam K (1978) Histological typing of nasopharyngealcarcinoma. IARC Sci Publ (20):3–12Shannon-Lowe C, Baldwin G, Feederle R, et al (2005) Epstein–Barr virus-induced B-cell transformation: quantitatingevents from virus binding to cell outgrowth. J Gen Virol86(Pt 11):3009–3019Shao YM, Poirier S, Ohshima H, et al (1988) Epstein–Barrvirus activation in Raji cells by extracts of preserved foodfrom high risk areas for nasopharyngeal carcinoma.Carcinogenesis 9(8):1455–1457Sheu LF, Chen A, Meng CL, et al (1997) Analysis of bcl-2 expressionin normal, inflamed, dysplastic nasopharyngeal epithelia,and nasopharyngeal carcinoma: association withp53 expression. Hum Pathol 28(5):556–562Shih-Hsin Wu L (2006) Construction of evolutionary treemodels for nasopharyngeal carcinoma using comparativegenomic hybridization data. Cancer Genet Cytogenet168(2):105–108Sixbey JW, Yao QY (1992) Immunoglobulin A-induced shiftof Epstein–Barr virus tissue tropism. Science 255(5051):1578–1580Smith P (2001) Epstein–Barr virus complementary strandtranscripts (CSTs//BARTs) and cancer. Semin Cancer Biol11(6):469–476Smith PR, de Jesus O, Turner D, et al (2000) Structure and codingcontent of CST (BART) family RNAs of Epstein–Barrvirus. J Virol 74(7):3082–3092